Cargando…
Melanogenic effect of dersimelagon (MT‐7117), a novel oral melanocortin 1 receptor agonist
BACKGROUND: The activation of melanocortin 1 receptor (MC1R) on melanocytes stimulates the production of eumelanin. A tridecapeptide α melanocyte‐stimulating hormone (αMSH) is known to induce skin pigmentation. OBJECTIVES: We characterised the properties of a novel oral MC1R agonist dersimelagon (MT...
Autores principales: | Suzuki, T., Kawano, Y., Matsumoto, A., Kondo, M., Funayama, K., Tanemura, S., Miyashiro, M., Nishi, A., Yamada, K., Tsuda, M., Sato, A., Morokuma, K., Yamamoto, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060023/ https://www.ncbi.nlm.nih.gov/pubmed/35665216 http://dx.doi.org/10.1002/ski2.78 |
Ejemplares similares
-
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis
por: Kondo, Masahiro, et al.
Publicado: (2022) -
Absorption, metabolism, and excretion of [
(14)C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
por: Tsuda, Minoru, et al.
Publicado: (2023) -
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist
por: Ogasawara, Akihito, et al.
Publicado: (2023) -
“Melanogenic Metaplasia” of Mucous Glands
por: Shivas, A. A., et al.
Publicado: (1963) -
Melanogenic Properties and Expression Profiles of Melanogenic Paracrine Molecules in Riehl’s Melanosis
por: Woo, Yu Ri, et al.
Publicado: (2020)